Arbutus Biopharma Corporation (LON:0SGC)
3.319
+0.010 (0.30%)
At close: Jan 31, 2025
Arbutus Biopharma Employees
Arbutus Biopharma had 44 employees as of December 31, 2024. The number of employees decreased by 29 or -39.73% compared to the previous year.
Employees
44
Change (1Y)
-29
Growth (1Y)
-39.73%
Revenue / Employee
255.73K GBP
Profits / Employee
-899.97K GBP
Market Cap
604.51M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 44 | -29 | -39.73% |
Dec 31, 2023 | 73 | -25 | -25.51% |
Dec 31, 2022 | 98 | 11 | 12.64% |
Dec 31, 2021 | 87 | 9 | 11.54% |
Dec 31, 2020 | 78 | -2 | -2.50% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
HSBC Holdings | 211,304 |
AstraZeneca | 94,300 |
Shell | 96,000 |
Unilever | 115,964 |
Rolls-Royce Holdings | 42,400 |
British American Tobacco p.l.c. | 48,989 |
Rio Tinto Group | 60,000 |
BP p.l.c. | 100,500 |